Alzheimer's Disease
2 articles on Alzheimer's Disease, written by Shotlee and medically reviewed for clinical accuracy.
Brain Insulin Resistance: Driving Alzheimer's as Type 3 Diabetes
Alzheimer's disease may be more than just amyloid plaques—emerging evidence points to brain insulin resistance as a core driver, earning it the label 'Type 3 diabetes.' A recent Polish study uncovers how impaired insulin signaling starves neurons of energy and accelerates toxic protein buildup. Discover the science and potential therapies like GLP-1 agonists that could change the game.
5 min read
Semaglutide Fails to Slow Alzheimer's Progression in Study
A recent clinical trial, Evoke, investigated semaglutide's potential to slow Alzheimer's disease. While the drug improved certain Alzheimer's-related biomarkers, it did not delay the disease's progression. Researchers emphasize the need for multi-faceted approaches to tackle Alzheimer's.
2 min read